Biopharmaceuticals
Venture Capital
News Release - January 26, 2022
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
Source: Kyverna Therapeutics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.